90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the international, randomized, phase III first-line indolent trial
Nom du journal : J Clin Oncol
Année : 2013
Volume : 31
Page de départ : 1977
Page de fin : 1983